Understand the source comparison
Comparison with Epithalon
Epithalon (Ala-Glu-Asp-Gly) demonstrates lower injection site reaction rates at 8-12% compared to Vilon's 15-20% incidence.[90] Gastrointestinal side effects occur less frequently with Epithalon (4-6% nausea rate) versus Vilon's 8-12% rate.[91] Both peptides s
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Epithalon (Ala-Glu-Asp-Gly) demonstrates lower injection site reaction rates at 8-12% compared to Vilon's 15-20% incidence.[90] Gastrointestinal side effects occur less frequently with Epithalon (4-6% nausea rate) versus Vilon's 8-12% rate.[91] Both peptides show similar lymphocyte activation patterns, with Epithalon producing slightly less pronounced immune responses.[92]